Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4806-4810

  Martins, Luciane ^a   Matsuo, Sílvia E ^a   Ebina, Kátia N ^a   Kulcsar, Marco Aurélio V ^a   Friguglietti, Celso U M ^a   Kimura, Edna T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; MESSENGER RNA;

BENIGN TUMOR; CANCER DIAGNOSIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NODULAR GOITER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ANTIGENS, DIFFERENTIATION; CARCINOMA, PAPILLARY; GALECTIN 3; GOITER; HUMANS; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036776236     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020094     Document Type: Review

References (41)

1. Perillo NL, Marcus ME, Baum LG 1998 Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 76:402-412
2. Chiariotti L, Salvatore P, Benvenuto G, Bruni CB 1999 Control of galectin gene expression. Biochimie (Paris) 81:381-388
3. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O 2001 Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357:1644-1650
4. Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J 1998 Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 18:2637-2641
5. Fernandez PL, Merino MJ, Gomez M, Campo E, Medina T, Castronovo V, Sanjuán X, Cardesa A, Liu F-T, Sobel ME 1997 Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 181:80-86
6. Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A 1999 Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 17:3494-3502
7. Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J-I, Hattori K, Okamoto S, Sawada T, Raz A, Kudo T 1999 Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 85:2475-2484
8. Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A 1998 Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 58:3015-3020
9. Saggiorato E, Cappia S, De Giuli P, Mussa A, Pancani G, Caraci P, Angeli A, Orlandi F 2001 Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 86:5152-5158
10. Xu XC, el-Naggar AK, Lotan R 1995 Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147:815-822
11. Derwahl M, Studer H 2002 Hyperplasia versus adenoma in endocrine tissues: Are they different? Trends Endocrinol Metab 13:23-28
12. Farid NR, Shi Y, Zou M 1994 Molecular basis of thyroid cancer. Endocr Rev 15:202-232
13. Agrawal S 1995 Diagnostic accuracy and role of fine needle aspiration cytology in management of thyroid nodules. J Surg Oncol 58:168-172
14. Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, Natsugoe S, Sueyoshi K, Aikou T, Sato E 2000 Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol 31:428-433
15. Hedinger C, Williams ED, Sobin LH 1989 The WHO histological classification of thyroid tumors: A commentary on the second edition. Cancer 63:908-911
16. Hedinger C, Willians ED, Sobin LH 1993 Histological typing of thyroid tumors. In: International Histological Classification of Tumours, World Health Organization, Ed 2. Berlin, Heidelberg, New York, London, Paris, Tokyo: Springer-Verlag
17. Rosai J, Carcangiu ML, DeLellis RA 1992 Tumors of the thyroid gland. In: Rosai J, Sobin LH. Atlas of Tumor Pathology. Third Series, Fascicle 5. Washington, DC: Armed Forces Institute of Pathology
18. Kimura ET, Kopp P, Zbaeren J, Asmis LM, Ruchti C, Maciel RM, Studer H 1999 Expression of transforming growth factor beta1, beta2, and beta3 in multinodular goiters and differentiated thyroid carcinomas: A comparative study. Thyroid 9:119-125
19. Liu FT, Hsu DK, Zuberi RI, Hill PN, Shenhav A, Kuwabara I, Chen SS 1996 Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains. Biochemistry 35:6073-6079
20. Dawson-Saunders B, Trapp RG 1994 Basic, Clinical Biostatistics, Ed 2. Norwalk: Appleton, Lange; 232-248
21. Sambrook J, Fristsch E, Marniatis T 1989 Molecular Cloning: A Laboratory Manual, Ed 2. New York: Cold Spring Harbor Laboratory Press
22. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ 1997 Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402
23. Fagin JA 1992 Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasia. J Clin Endocrinol Metab 75:1398-1400
24. Kopp P, Kimura ET, Aeschimann S, Oestreicher M, Tobler A, Fey MF, Studer H 1994 Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab 79:134-139
25. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G 2002 Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 40:80-87
26. Berberat PO, Friess H, Wang L, Zhu Z, Bley T, Frigeri L, Zimmermann A, Buchler MW 2001 Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. J Histochem Cytochem 49:539-549
27. Schaffert C, Pour PM, Chaney WG 1998 Localization of galectin-3 in normal and diseased pancreatic tissue. Int J Pancreatol 23:1-9
28. Wang L, Friess H, Zhu Z, Frigeri L, Zimmermann A, Korc M, Berberat PO, Buchler MW 2000 Galectin-1 and galectin-3 in chronic pancreatitis. Lab Invest 80:1233-1241
29. Hsu DK, Dowling CA, Jeng KC, Chen JT, Yang RY, Liu FT 1999 Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 81:519-526
30. Van den Brule FA, Berchuck A, Bast RC, Liu FT, Gillet C, Sobel ME, Castronovo V 1994 Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur J Cancer 8:1096-1099
31. Castronovo V, Van Den Brule FA, Jackers P, Clausse N, Liu FT, Gillet C, Sobel ME 1996 Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 179:43-48
32. Van den Brule F A, Waltregny D, Liu FT, Castronovo V 2000 Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer 89:361-367
33. Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J-I, Hattori K, Tomiyama Y, Raz A, Kubo T 2000 Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 6:4635-4640
34. Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, Raz A 1998 Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology 115:287-296
35. Lee EC, Woo HJ, Korzelius CA, Steele Jr GD, Mercurio AM 1991 Carbohydrate-binding protein 35 is the major cell-surface laminin-binding protein in colon carcinoma. Arch Surg 126:1498-1502
36. Lotz MM, Andrews Jr CW, Korzelius CA, Lee EC, Steele Jr GD, Clarke A, Mercurio AM 1993 Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 90:3466-3470
37. Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL 2001 Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol Metab 86:2187-2190
38. Fusco A, Grieco M, Santoro M, Berlingieri MT, Pilotti S, Pierotti MA, Della Porta G, Vecchio G 1987 A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 328:170-172
39. Fagin JA 2002 Perspective: Lessons learned from molecular genetic studies of thyroid cancer insights into pathogenesis and tumor-specific therapeutic targets. Endocrinology 143:2025-2028
40. Fuhrer D 2001 A nuclear receptor in thyroid malignancy: Is PAX8/PPARγ the Holy Grail of follicular thyroid cancer? Eur J Endocrinol 144:453-456
41. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma [corrected]. Science 289:1357-1360